RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARDS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Aridis Pharmaceuticals Inc. stock upgraded from Sell Candidate to Buy Candidate after Thursday trading session.
(Updated on Mar 28, 2024)

Buy candidate since Mar 28, 2024 PDF

The Aridis Pharmaceuticals Inc. stock price gained 4.35% on the last trading day (Thursday, 28th Mar 2024), rising from $0.0748 to $0.0780. During the last trading day the stock fluctuated 9.09% from a day low at $0.0715 to a day high of $0.0780. The price has been going up and down for this period, and there has been a -7.14% loss for the last 2 weeks. Volume fell on the last day by -16 thousand shares and in total, 19 thousand shares were bought and sold for approximately $1.47 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.35% during the next 3 months and, with a 90% probability hold a price between $0.0758 and $0.0998 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ARDS Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, March 14, 2024, and so far it has fallen -7.14%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. The Aridis Pharmaceuticals Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0757 and $0.0754. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Aridis Pharmaceuticals Inc. stock

Aridis Pharmaceuticals Inc. finds support from accumulated volume at $0.0750 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0065 between high and low, or 9.09%. For the last week the stock has had daily average volatility of 7.79%.

Our recommended stop-loss: $0.0742 (-4.93%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 10 days ago.)

Trading Expectations (ARDS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Aridis Pharmaceuticals Inc. to open at $0.0758, and during the day (based on 14 day Average True Range), to move between $0.0717 and $0.0843, which gives a possible trading interval of +/-$0.0063 (+/-8.13%) up or down from last closing price. If Aridis Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 16.26% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0800 (2.56%) than the support at $0.0750 (3.85%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aridis Pharmaceuticals Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Aridis Pharmaceuticals Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.971 Buy Candidate Upgraded

Predicted Opening Price for Aridis Pharmaceuticals Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.0758 ( 2.78%) $0.0780

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARDS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0823 5.56 %
R2 0.0799 2.37 %
R1 0.0783 0.406 %
Current price: 0.0780
Support S1 0.0734 -5.96 %
S2 0.0718 -7.93 %
S3 0.0693 -11.11 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0895 14.74 %
R2 0.0840 7.69 %
R1 0.0800 2.56 %
Current price 0.0780
Support S1 0.0750 -3.85%
S2 0.0690 -11.54%
S3 0.0680 -12.82%

FAQ

What is the symbol for Aridis Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Aridis Pharmaceuticals Inc. is ARDS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aridis Pharmaceuticals Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Aridis Pharmaceuticals Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Aridis Pharmaceuticals Inc. Stock?
Aridis Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aridis Pharmaceuticals Inc. Stock.

What's the current price of Aridis Pharmaceuticals Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Aridis Pharmaceuticals Inc. (ARDS) share was $0.0780.

What is the 52-week high and low for Aridis Pharmaceuticals Inc. Stock?
The 52-week high for Aridis Pharmaceuticals Inc. Stock is $0.540 and the 52-week low is $0.0500.

What is the market capitalization of Aridis Pharmaceuticals Inc. Stock?
As of the 2024-03-28, the market capitalization of Aridis Pharmaceuticals Inc. is 3.332M.

When is the next earnings date for Aridis Pharmaceuticals Inc.?
The upcoming earnings date for Aridis Pharmaceuticals Inc. is May 27, 2024.
Click to get the best stock tips daily for free!

About Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals. Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-32... ARDS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT